Bay­er drops $460M in­to con­tra­cep­tive man­u­fac­tur­ing sites with the Unit­ed Na­tion­s' back­ing

Bay­er will in­vest $460 mil­lion in­to two man­u­fac­tur­ing sites to ex­pand its pro­duc­tion ca­pa­bil­i­ties for con­tra­cep­tives to low- and mid­dle-in­come coun­tries.

Through a deal in­volv­ing the UN Pop­u­la­tion Fund and the US Agency for In­ter­na­tion­al De­vel­op­ment, Bay­er’s ex­pand­ing one site in Turku, Fin­land, and build­ing an­oth­er in Ala­juela, Cos­ta Ri­ca, to pro­duce hor­mon­al im­plants and in­trauter­ine sys­tems. The in­vest­ments help Bay­er move to­ward its goal of pro­vid­ing 100 mil­lion girls and women with ac­cess to fam­i­ly plan­ning by 2030, as well as help boost its com­mer­cial sup­ply chain.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER